8-K - Akari Therapeutics, Plc | StockGist

Current Report Details

Event Type

Shareholder Vote

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.07

. Submission of Matters to a Vote of Security Holders. On December 15, 2025 Akari Therapeutics, Plc (the “Company”) held a general meeting of shareholders of th

Shareholder Vote

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. SIG

Exhibits Only

Exhibits (1)

8-K